Questcor Pharmaceuticals to Present at JMP Securities Healthcare ... ( ANAHEIM Calif. July 2 2012 /- Questco...)

Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference

Date:7/2/2012

ANAHEIM, Calif., July 2, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the JMP Securities Healthcare Conference in New York on July 13, 2012 at 8:00 a.m. PT / 11:00 a.m. ET.

A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm. The replay will be available for approximately 90 days after the event.

About Questcor

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications. Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of proteinuria in idiopathic types of nephrotic syndrome, the treatment of acute exacerbations of multiple sclerosis in adults, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus." Questcor is also currently preparing to
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
2. Pharmaceuticals: Global Industry Almanac, MarketLine
3. Prodigy Health Supplier Partners with Stason Pharmaceuticals to Help Relieve U.S. Drug Shortages
4. Nouveau Life Pharmaceuticals (NOUV) to Launch Affiliate Sales Program
5. Trading Of Onyx Pharmaceuticals Common Stock Halted
6. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
7. ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum
8. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
9. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
10. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
11. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals

Post Your Comments:

(Date:5/18/2013)... 2013 The Open Paradigm Project, in ... Occupy Psychiatry , and leading organizations in the ... social media campaign showcasing video testimonials by individuals ... focuses on pathology and illness rather than wellness ... Psychiatric Association,s (APA) rollout of its latest revision ...

(Date:5/17/2013)... -- Medical devices are any medical items that are ... of their different mechanisms, actions and regulatory requirements, medical ... drug trails due to their unique clinical practices. Currently, ... both safety and efficacy (which is left to the ... as the SFDA) evaluate MDs for both safety and ...

(Date:5/17/2013)... , May 17, 2013 Orexigen® Therapeutics, Inc. (Nasdaq: ... a company overview at the UBS Global Healthcare Conference in ... for Wednesday, May 22 nd at 11 a.m. Eastern ... of the presentation, please visit the Investor Relations section of ... will be available for 14 days after the event. ...

Breaking Medicine Technology:New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2 New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3 Statistical Challenges in Medical Device Trail Evaluation 2

[0] New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses [0] Statistical Challenges in Medical Device Trail Evaluation [0] Orexigen Therapeutics to Present at the UBS Global Healthcare Conference

... ADD NEW CENTERS AND TO ... INCREASE AWARENESS AMONG CARDIOLOGISTS, PLEASANTON, Calif., April 21 ... device-based mechanical,circulatory support therapies to save, support and restore failing ... PMA (PreMarket,Approval) application, allowing the use of its HeartMate II ...

... EDISON, N.J., April 21 Nostrum, a ... today that it has,successfully completed its early, ... protein currently known as SMRX11. Nostrum,s,Symmetrix subsidiary, ... drug under Nostrum,s license from the Institute ...

Cached Medicine Technology:Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 2 Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 3 Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 4 Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 5 Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein 2

Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein

(Date:5/20/2013)... (PRWEB) May 20, 2013 iGearUnlimited.com asked schools' ... iPad case for students. The answers didn't surprise anyone: , ... daily use and abuse, 2. Not too bulky – need ... backpack, 3. Built-in kick-stand that works in both vertical and ... as a trackable barcodes on each case, 5. Customizable – ...

(Date:5/20/2013)... Atlanta, GA (PRWEB) May 20, 2013 ... opening of their newest office on Briarcliff Road in ... urgent care facility includes Dr. Fidias E. De ... massage therapists who will provide extensive medical services, occupational ... of the greater Atlanta metropolitan area. They also offer ...

(Date:5/20/2013)... OH (PRWEB) May 20, 2013 The ... experienced medical device law firm, report that two important ... coming months in state and federal litigations established for ... June 11th, the first C.R. Bard bellwether trial will ... Southern District of West Virginia. (In re: C.R. ...

(Date:5/19/2013)... NY (PRWEB) May 20, 2013 Alonso ... they are representing a New York woman in a ... with the National Football League (NFL). According to an ... Petitioner is seeking a declaration of paternity, order of support ... of her son with Mr. Walker. (Docket No. P-18821-13) ...

(Date:5/19/2013)... measure of the heterogeneity the variety of genetic mutations ... outcomes of patients with the most common type of head ... the journal Cancer , investigators at Massachusetts General Hospital ... measure was a better predictor of survival than most traditional ... cell carcinoma of the head and neck. , ...

Breaking Medicine News(10 mins):Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 2 Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 3 Health News:Healing Heart Urgent Care Opens New Office In Atlanta 2 Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 2 Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 3 Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 4 Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 2 Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 3 Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 2 Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 3

[0] New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments [0] Healing Heart Urgent Care Opens New Office In Atlanta [0] Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials [0] New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner [0] Genetic diversity within tumors predicts outcome in head and neck cancer

... 91% Increase in Earnings for First Half of 2008 ... Metropolitan,Health Networks, Inc. (Amex: MDF ), a ... results for the six months,and quarter ended June 30, ... that in the three months ended,June 30, 2008, the ...

... /Xinhua-PRNewswire/ -- Simcere Pharmaceutical,Group (NYSE: SCR ), a ... of the patented anti-cancer biotech,product Endu in China, today ... 2008., Highlights -- Total revenue increased ... second quarter, representing a 30.4% year-over-year growth;, ...

... Year-over-Year to $10.7 Million Backlog Reaches $72 ... Million ... to Market Recently-introduced Odyssey System Building Strong Market Momentum, ST. ... second quarter ended June,30, 2008. Revenue for the recent second quarter increased 36% ...

... goes for gold and aims to give back to Mercy Ships ... ... Laser Champion and one of Britain,s greatest medal hopes at the Beijing ... charity Mercy Ships which provides free medical care to the people of ...

... major website re-design, aimed specifically toward potential clients, with improved ... ... New York, NY (PRWEB) August 5, 2008 -- ... re-design, aimed specifically toward potential clients, with improved navigability, clear ...

... esignature, Princor representatives now benefit from a more efficient account ... ... Ontario, CA (PRWEB) August 5, 2008 -- Interlink Electronics, Inc. ... Corporation, a member of the Principal Financial Group®. The Princor® ...

Metropolitan Health Networks Reports 2008 Second Quarter Results Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results Stereotaxis Reports Record Second Quarter Revenue Olympic Sailing Hopeful Backs Hospital Ship Charity Re-Designed Legal Website Includes Blog Interlink and LaserApp Partnership Provides eSignature-Ready Forms to Princor Financial Services

The Easy Wrap Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is available in 5mm lea...

... system is a long term, ... clinically proven design. Available in ... correct cruciate retaining configurations. In ... of identification keeps the user ...

... The Genesis II® Total Knee System ... Now, far more is possible with less ... options, while fully addressing both clinical and ... meet these design goals, giving surgeons creative ...

Cementless hip system...

Medicine Products:

Easy Wrap Apron w/Collar: Lead Free Proven™ Posterior Stabilized Knee System Genesis II® Total Knee System Primaloc™ Cementless